Literature DB >> 14102687

CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMA.

L G BARTHOLOMEW, J C CAIN, R K WINKELMANN, A H BAGGENSTOSS.   

Abstract

Entities:  

Keywords:  LIVER CIRRHOSIS, POSTNECROTIC; PATHOLOGY; SCLERODERMA

Mesh:

Year:  1964        PMID: 14102687     DOI: 10.1007/BF02232678

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  10 in total

1.  Further obervations on hepatitis and cirrhosis in young women with positive clot tests for lupus erythematousus.

Authors:  L G BARTHOLOMEW; J C CAIN; A H BAGGENSTOSS; A B HAGEDORN
Journal:  Gastroenterology       Date:  1960-12       Impact factor: 22.682

2.  Diffuse systemic scleroderma. A comparison with acrosclerosis.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

3.  Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus.

Authors:  L G BARTHOLOMEW; A B HAGEDORN; J C CAIN; A H BAGGENSTOSS
Journal:  N Engl J Med       Date:  1958-11-13       Impact factor: 91.245

4.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

5.  Ascites. II. The value of determinations of enzymes in the study of ascitic fluid.

Authors:  G A FLEISHER; L G BARTHOLOMEW; J C CAIN; R A ROVELSTAD
Journal:  Gastroenterology       Date:  1959-09       Impact factor: 22.682

6.  Generalized scleroderma involving lungs and liver with pulmonary adenocarcinoma.

Authors:  J G BATSAKIS; H A JOHNSON
Journal:  Arch Pathol       Date:  1960-06

7.  Ascites. IV. Clinical appraisal of the laboratory studies of ascitic fluid and blood as an aid to diagnosis.

Authors:  R A ROVELSTAD; L G BARTHOLOMEW; J C CAIN
Journal:  Gastroenterology       Date:  1959-09       Impact factor: 22.682

8.  Scleroderma of the gastrointestinal tract; a review.

Authors:  M B GOLDGRABER; J B KIRSNER
Journal:  AMA Arch Pathol       Date:  1957-09

9.  Systemic scleroderma with portal hypertension.

Authors:  R J CALVERT; B BARLING; M SOPHER; M FEIWEL
Journal:  Br Med J       Date:  1958-01-04

10.  Ascites. I. The value of examination of ascitic fluid and blood for lipids and for proteins by electrophoresis.

Authors:  R A ROVELSTAD; L G BARTHOLOMEW; J C CAIN; B F McKENZIE; E H SOULE
Journal:  Gastroenterology       Date:  1958-03       Impact factor: 22.682

  10 in total
  11 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Hepatocyte giant mitochondria: an almost constant lesion in systemic scleroderma.

Authors:  G Feldmann; M Maurice; J M Husson; J N Fiessinger; J P Camilleri; J P Benhamou; E Housset
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-06-23

Review 3.  The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.

Authors:  Cumali Efe; Ersan Ozaslan; Narin Nasiroglu; Hasan Tunca; Tugrul Purnak; Emin Altiparmak
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

4.  Transient ascites in progressive systemic sclerosis.

Authors:  J J McAleer; S R Cunningham; W Dickey; D Burrows; M E Callender
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 5.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

6.  Rheumatic disorders in primary biliary cirrhosis.

Authors:  A K Clarke; R M Galbraith; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  Evaluation of liver function tests in scleroderma patients.

Authors:  Gehan Ibrahim Abdelrazek Salem; Awni Ali Abdulrahman
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

8.  Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis.

Authors:  R C Gupta; J R Seibold; M R Krishnan; J C Steigerwald
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Diffuse systemic sclerosis with abnormal liver and gall bladder.

Authors:  P W Copeman; W E Medd
Journal:  Br Med J       Date:  1967-08-05

10.  Scleroderma and primary biliary cirrhosis.

Authors:  I M Murray-Lyon; R P Thompson; I D Ansell; R Williams
Journal:  Br Med J       Date:  1970-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.